Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Christian Buske

14PUBLICATIONS
93CO-AUTHORS
Medical mycologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyCounselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

Sort by Publication Date:
|Mar 06, 2026
Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registry.

Alexander Grunenberg, Birgit Schmelzle, Jacqueline Gökeler

|Dec 05, 2025
Molecular Plasticity Results in Oncofetal Reprogramming and Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia.

Mark Hartmann, Maximilian Schönung, Jovana Rajak

|Mar 07, 2024
There's life in the old dog yet: immunochemotherapy in Waldenström's macroglobulinemia.

Efstathios Kastritis, Christian Buske

|Jul 21, 2023
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.

Meletios A Dimopoulos, Stephen Opat, Shirley D'Sa

|Jun 22, 2023
Reply to S. Sarosiek et al.

Christian Buske, Meletios A Dimopoulos, Pierre Morel

|Feb 10, 2023
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia.

Christian Buske, Meletios A Dimopoulos, Alexander Grunenberg

Pageof 3

Frequent Collaborators

6 joint publications

Meletios A Dimopoulos

4 joint publications

Efstathios Kastritis

4 joint publications

Steven P Treon

3 joint publications

Jorge J Castillo

3 joint publications

Constantine S Tam

3 joint publications

Pierre Morel

3 joint publications

Ramón García-Sanz

3 joint publications

Judith Trotman

2 joint publications

M Lia Palomba

2 joint publications

Dipti Talaulikar

Frequent Collaborators

6 joint publications

Meletios A Dimopoulos

4 joint publications

Efstathios Kastritis

4 joint publications

Steven P Treon

3 joint publications

Jorge J Castillo

Top Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on : Sep 12, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on : Feb 21, 2018

10.4K
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on : Jun 29, 2016

14.1K
See more related videos

Top Related Videos

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on : Sep 12, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on : Feb 21, 2018

10.4K
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on : Jun 29, 2016

14.1K
See more related videos